Myriad Genetics, Inc. (FRA:MYD)

Myriad Genetics Revenue

Myriad Genetics had revenue of $205.70M USD in the quarter ending September 30, 2025, a decrease of -3.56%. This brings the company's revenue in the last twelve months to $825.30M, up 0.21% year-over-year. In the year 2024, Myriad Genetics had annual revenue of $837.60M with 11.21% growth.

• Revenue (ttm): $825.30M
• Revenue Growth: +0.21%
• P/S Ratio: 0.87
• Revenue / Employee: $305.67K
• Employees: 2,700
• Market Cap: 613.36M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	837.60M	84.40M	11.21%
Dec 31, 2023	753.20M	74.80M	11.03%
Dec 31, 2022	678.40M	-12.20M	-1.77%
Dec 31, 2021	690.60M	133.50M	23.96%
Dec 31, 2020	557.10M	-81.50M	-12.76%
Sep 30, 2020	638.60M	-	-
Jun 30, 2020	638.60M	-212.50M	-24.97%
Jun 30, 2019	851.10M	107.40M	14.44%
Jun 30, 2018	743.70M	15.00M	2.06%
Jun 30, 2017	728.70M	-11.80M	-1.59%
Jun 30, 2016	740.50M	17.40M	2.41%
Jun 30, 2015	723.10M	-55.10M	-7.08%
Jun 30, 2014	778.20M	165.00M	26.91%
Jun 30, 2013	613.20M	117.20M	23.63%
Jun 30, 2012	496.01M	93.92M	23.36%
Jun 30, 2011	402.08M	39.44M	10.87%
Jun 30, 2010	362.65M	36.12M	11.06%
Jun 30, 2009	326.53M	103.67M	46.52%
Jun 30, 2008	222.86M	77.57M	53.39%
Jun 30, 2007	145.29M	31.01M	27.13%
Jun 30, 2006	114.28M	-	-